Penile shaft hypopigmentation: Lichen sclerosus occurring after the initiation of alprostadil intracavernous injections for erectile dysfunction

Journal of the American Academy of Dermatology

Volumn 39, Issue 5 I, 1998, Pages 801-803

  English III, J C ^a   King, D H C ^a   Foley, J P ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E1;

ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; HUMAN; HYPOPIGMENTATION; IMPOTENCE; INJECTION SITE; LICHEN SCLEROSUS ET ATROPHICUS; MALE; PENIS; PRIORITY JOURNAL;

EID: 0031742336     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(98)70057-X     Document Type: Article

References (18)

1. JJ Meffert BM Davis RE. Grimwood Lichen sclerosus J Am Acad Dermatol 32 1995 393 416
2. JC English III RA Laws GC Keough JL Wilde JP Foley DM. Elston Dermatoses of the glans penis and prepuce J Am Acad Dermatol 37 1997 1 24
3. RHM Meyrick Thomas CM Ridley MM. Black Clinical features and therapy of lichen sclerosus et atrophicus affecting males Clin Exp Dermatol 12 1987 126 128
4. Intracavernous injection of alprostadil for erectile dysfunction Med Lett 37 1995 83 84
5. H. Porst The rationale for prostaglandin E1 in erectile failure: a survey of world experience J Urol 155 1996 802 815
6. OI Linet FG. Orginc Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction N Engl J Med 334 1996 873 877
7. OI Linet LL. Neff Intracavernous prostaglandin E1 in erectile dysfunction Clin Invest 72 1994 139 149
8. J Chen Godschalk G Katz T. Mulligan Peyronie’s-like plaque after penile injection of prostaglandin E1 J Urol 152 1994 961 962
9. RN Chen MM Lakin DK Montague S. Ausmundson Penile scarring with intracavernous injection therapy using prostaglandin E1: a risk factor analysis J Urol 155 1996 138 140
10. P Marren J Yell FM Charnock M Bunce K Welsh F. Wojnarowska The association between lichen sclerosus and antigens of the HLA system Br J Dermatol 132 1995 197 203
11. FE Clay MJ Cork JK Tarlow AI Blakemore CI Harrington F Lewis Interleukin 1 receptor antagonist gene polymorphism associated with lichen sclerosus Hum Genet 94 1994 407 410
12. P Carli S Moretti A Spallanzani E Berti A. Cattaneo Fibrogenic cytokines in vulvar lichen sclerosus: an immunohistochemical study J Reprod Med 42 1997 161 165
13. RB Moreland A Traish MA McMillian B Smith I Goldstein I. Saenz de Tejada PGE1 suppresses the induction of new collagen synthesis by transforming growth factor B1 in human corpus cavernosum smooth muscle cells: mechanism of action of penile ischemia associated fibrosis [abstract 815] J Urol 151 1994 431A
14. AP. Lupulescu Cytologic and metabolic effects of prostaglandins on rat skin J Invest Dermatol 68 1977 138 145
15. JZ Zhang K Maruyama K Iwatsuki I Ono F. Kaneko Effects of prostaglandin E1 on human keratinocytes and dermal fibroblasts: a possible mechanism for the healing of skin ulcers Exp Dermatol 3 1994 164 170
16. P Paquet G. Pierard Interleukin-6 and the skin Int Arch Allergy Immunol 109 1996 308 317
17. MR Ducan B. Berman Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human IL-6 J Invest Dermatol 97 1991 686 692
18. CA Feghali KL Bost DW Boulware L. Levy Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis Autoimmunity 17 1994 309 318